Search

Monday, October 15, 2007

Yoga can give women with breast cancer a boost

Yoga
Special yoga classes can significantly improve the quality of life and well being of women with breast cancer patients -- particularly those who are not taking chemotherapy -- a new study shows.

A diverse group of low-income women participated in the study, Dr. Alyson B. Moadel of the Albert Einstein College of Medicine in the Bronx, New York, noted in an interview with Reuters Health. "Our patients really enjoyed the yoga classes, it was very well received by them," she said. "It really fit in with their own cultural interests."

There is mounting evidence that yoga can improve quality of life in both healthy and chronically ill people, Moadel and her team point out in the Journal of Clinical Oncology, while quality of life may be particularly affected for cancer survivors who belong to ethnic minorities and other underserved minority populations.

To investigate whether yoga could help cancer patients and survivors feel better, the researchers randomly assigned 128 women to a 12-week yoga intervention or a wait list "control" group.

Classes were offered three times a week, and participants were urged to attend at least one class a week, and also instructed to do the exercises at home with the help of an audiotape. The Hatha yoga-based exercises had been developed especially for breast cancer patients by one of the study's authors, and were done while participants were either sitting in a chair or lying down.

During the course of the study, patients in the control group showed greater declines in well being than women in the yoga group. When the researchers omitted patients undergoing chemotherapy from their analysis, they found that the women who did yoga showed improvements in quality of life; greater emotional, social and spiritual well being; and less distress.

People often feel fatigued and sick while undergoing chemo, Moadel noted, which is likely why yoga didn't appear to be helpful for study participants on chemotherapy...


Via Reuters




Share this Post with other

No comments: